Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma
Conditions: Multiple Myeloma in Relapse; Plasmacytoma; Daratumumab Intervention: Drug: Drug Combinations Sponsor: Seoul National University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials